第三阶段N2肺癌:一个多学科的治疗难题
Lily Carter1, Vedika Apte2,3, Arushi Shukla4,5,6
1Division of Surgery, Cancer and Cardiovascular Medicine, Imperial College Healthcare NHS Trust, London, UK.
Current oncology reports
|January 5, 2024
概括
对第三阶段N2非小细胞肺癌 (NSCLC) 的治疗进行了辩论. 关于切除性定义的指导方针各不相同,影响了这种复杂癌症的治疗决策. 多学科团队对于个性化护理至关重要.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 肺部病理学 肺部病理学
背景情况:
- 第三阶段N2非小细胞肺癌 (NSCLC) 治疗缺乏关于切除能力的普遍共识.
- 第三阶段N2NSCLC中的异质性有助于治疗辩论和有限的试验数据.
研究的目的:
- 审查和比较管理第三阶段N2NSCLC的国际指导方针.
- 分析有关第三阶段N2 NSCLC的切除能力和治疗选择的证据.
主要方法:
- 对当前国际指南 (爱尔兰,澳大利亚,美国,英国) 的比较分析.
- 对第三阶段N2NSCLC的手术切除,放射治疗,化疗和免疫治疗的证据的审查.
主要成果:
- 国际指南在分类N2疾病 (N2a/N2b) 和强调多学科团队 (MDT) 决策方面存在差异.
- 切除III期瘤的证据较弱;IIIA期通常被认为是切除的,IIIB期不推.
- 切除性疾病的治疗选择包括使用新辅助化学免疫疗法或辅助化疗/免疫疗法/放射治疗的手术.
- 仅仅放射治疗可能会产生类似于技术上可切除疾病的切除的结果.
- 化学辐射疗法与免疫疗法显示出对不可切除的疾病的前景.
结论:
- 定义第三阶段N2 NSCLC的切除性需要仔细考虑患者因素,团队专业知识和当地资源.
- 在确定切除能力和制定III期N2NSCLC的个性化治疗计划方面,MDT起着至关重要的作用.
- 第三阶段N2NSCLC的治疗策略正在发展,免疫疗法在组合疗法中扮演着新兴的角色.
相关概念视频
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K